MyFinsight
Home
Blog
About
Total comprehensive
loss
-$834,720
(30.75%↑ Y/Y)
Net loss
-$832,829
(30.84%↑ Y/Y)
Unrealized gain (loss) on
short-term debt...
-$1,891
(-65.88%↓ Y/Y)
Gain on debt
settlement
$91,645
Interest and dividend
income, net
$39,155
Unrealized gain on
short-term tokenized...
$4,961
Staking income on crypto
assets
$1,147
Net realized gain on
short-term debt...
$857
Loss before
provision for income taxes
-$832,829
(30.84%↑ Y/Y)
Total other income,
net
$96,120
Unrealized loss on crypto
assets, at fair value
-$35,795
Interest expense
$2,865
Realized loss on crypto
assets
-$2,073
Foreign currency
transaction loss
-$912
Loss from operations
-$928,949
Total operating
expenses
$928,949
Professional fees
$311,846
Research and development
$298,418
Compensation expense
$222,684
Other selling,
general and...
$96,001
Back
Back
Income Statement
Silo Pharma, Inc. (SILO)
Silo Pharma, Inc. (SILO)
source: myfinsight.com